DrugPatentWatch Database Preview
KEVEYIS Drug Profile
» See Plans and Pricing
When do Keveyis patents expire, and what generic alternatives are available?
Keveyis is a drug marketed by Strongbridge Us and is included in one NDA.
The generic ingredient in KEVEYIS is dichlorphenamide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
Summary for KEVEYIS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 77 |
| Patent Applications: | 2,238 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for KEVEYIS |
| DailyMed Link: | KEVEYIS at DailyMed |
Pharmacology for KEVEYIS
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for KEVEYIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strongbridge Us | KEVEYIS | dichlorphenamide | TABLET;ORAL | 011366-002 | Aug 7, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
